In contrast to the well-documented high prevalence of overweight and obesity in the general population, the prevalence, recognition rates and management by primary care physiciansFas the core gatekeeper in the health care systemFremains poorly studied. PURPOSE OF THE STUDY: To examine (1) the point prevalence of overweight (BMI 25.0-29.9 kg/m 2 ) and obesity (BMIZ30 kg/ m 2 ) in primary care patients, (2) prevalence patterns in patients with high-risk constellations (diabetes, hypertension, cardiovascular disease, etc.), (3) doctors' recognition and interventions, as well as patients' use and perceived effectiveness of weight-loss interventions and (4) factors associated with non-treatment. METHODS: Cross-sectional point prevalence study of 45 125 unselected consecutive primary care attendees recruited from a representative nationwide sample of 1912 primary care practices. Measures: (1) standardized clinical appraisal of each patient by the physician (diagnostic status and recognition, severity, comorbidity, current and past interventions). (2) Patient self-report questionnaire: height and weight, illness history, past and current treatments and their perceived effectiveness, health attitudes and behaviors. RESULTS: (1) In all, 37.9% of all primary care attendees were overweight, 19.4% obese. (2) Rates for overweight and obesity were highest in patients with diabetes (43.6 and 36.7%) and hypertension (46.1 and 31.3%), followed by patients with cardiovascular disorders. Rates of overweight/obesity increased steadily by the number of comorbid conditions. (3) Doctors' recognition of overweight (20-30%) and obesity (50-65%) was low, patients' actual use of weight control interventions even lower (past 12 months: 8-11%, lifetime: 32-39%). Patient success rates were quite limited. (4) Co-and multimorbidity in particular as well as other patient and illness variables were identified as predictors for recognition, but prediction of patients' actual use of weight loss interventions was limited. CONCLUSIONS: Primary care management of overweight and obesity is largely deficient, predominantly due to four interrelated factors: doctors' poor recognition of patients' weight status, doctors' inefficient efforts at intervention, patients' poor acceptance of such interventions and dissatisfaction with existing life-style modification strategies.
Introduction
There is an abundance of community data, documenting high and further increasing prevalence rates of overweight and obesity in most industrialized countries. 1, 2 The primary care physician's task as the gatekeeper of our health care system should be to recognize these patients and initiate intervention early. However, there is a remarkable lack of data on the prevalence of excess body weight in primary care. Accordingly, little is known about the extent to which overweight and obesity are recognized and managed. 3, 4 A better understanding of the recognition and the management of overweight and obesity is of significant interest for a number of reasons: (1) Obesity is of critical importance for a wide variety of health outcomes, such as increased rates of as well as a poorer course and outcome of diabetes, hypertension and cardiovascular disease. 5, 6 (2) Primary care doctors are gatekeepers for recognition, diagnosis, and subsequent referral and treatment, 7 not infrequently over decades of the patients life. (3) Early recognition and treatment of overweight and obesity may reduce the risk for secondary complications, improve its further course and reduce costs of treatment. 8, 9 In contrast, insufficient weight control among high-risk patients can increase the risk for comorbidity. (4) In comparison to the general population, primary care patients may represent a population with higher risk compared to the general population, due to their higher degree of acute and chronic morbidity, offering the opportunity to collect data about barriers and problems that could be used to identify factors associated with poor or insufficient recognition and treatment of overweight and obese patients.
In this paper, we explored the recognition and treatment of overweight and obesity in primary care. Particular focus was laid on high-risk patients with hypertension, diabetes and associated conditions. Furthermore, we aimed to identify the relative contribution of doctors' and patients' current and past attitudes and behaviors to the widespread failure of weight control measures.
Methods

HYDRA study design
The design and instruments of HYDRA have been presented in greater detail elsewhere 7, 10 (see also http://www. hydrastudie.de). Briefly, HYDRA is based on a two-step epidemiological design. In step one, a nation-wide sample (original n ¼ 2466) of primary care doctors completed a prestudy questionnaire (n ¼ 1912; response rate: 79%) to describe the personal and structural characteristics of each practice and to assess self-perceived qualifications and attitudes related to recognition, diagnosis and care of primary care patients. The second step consisted of a target day assessment (half day, alternatively September 18 or 20, 2001 ) of all consecutive patients attending the doctor's offices on this half-day. All patients were asked for consent and completed a self-report patient questionnaire, followed by a structured doctor's clinical appraisal, including documentation of lab test findings from the charts, blood pressure measurements and assessment of albuminuria and urine glucose. A total of n ¼ 45 125 patients were enrolled.
Instruments and measures
A comprehensive self-report patient questionnaire was used on the target day to assess the current complaints and illnesses, current and past treatment and utilization history as well as health attitudes and behaviors. Data on past lifetime and 12-month utilization of various types of weight reduction measures, that went beyond a simple doctors' advice to loose weight, were also assessed (nutritional courses, physical activity, stress reduction, specific blood pressure courses, specific diabetes courses, diabetes and hypertension self-help groups and organizations). Patients who had never participated in their lifetime in any 'course' or 'intervention' for weight reduction or taken part in nutrition counseling, physical activity, or related educational activities were classified as patients with 'no intervention'. Patients with at least one such intervention were asked how many times they had participated in such courses in the past 12 months and to evaluate the perceived success (none at all, some success, successful).
In the corresponding doctor's clinical appraisal, recognition of overweight and obesity was defined by doctors' assignment of a diagnosis of either overweight or obesity. Need for weight control intervention was calculated from the doctors' response to the question 'Which of the following non-drug interventions are indicated for the patient?' Codable response options were nutrition counseling and up to five other interventions aimed at reducing weight or increase physical activity.
Furthermore, the doctor was asked to rate the current presence and severity of a total of 22 specified medical conditions and, additionally, to supplement the default list by any further diagnosis. Doctors were trained in study procedures and reminded to code each medical condition listed. Severity ratings were based on the Clinical Global Impression Scale (CGI: not present, borderline, mild/moderate, severe/extreme).
11
Associations for overweight and obesity with these disorders were calculated.
Body mass index
Body weight and height information were derived from the patient's questionnaire. The body mass index (BMI) was calculated (bodyweight in kg/height in m Comparison with community data The General Health Survey (GHS) 1998 data were used to examine whether prevalence rates in primary care differ from those in the general population. The GHS was a nationally representative community survey 12, 13 of 7124 subjects aged 18-79 (response rate 61.4 %) in Germany, designed to provide data about the prevalence of major mental and somatic disorders. It also included a standardized measurement of height and weight and thus the BMI. For the matched comparison Z80 y were omitted, since the HYDRA primary care sampleFas opposed to the GHS dataFalso includes a large number of patients aged Z80 y.
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Statistical analyses
The total prevalence estimates reported from HYDRA are based on n ¼ 42.994 cases with complete BMI information. For comparisons between the HYDRA primary care and the GHS community sample, the HYDRA age range was restricted to 18-79 y (n ¼ 40.885). Odds ratios (ORs) from multinomial logistic regressions 14 were calculated to quantify the differences of prevalences of BMI categories between the HYDRA and the GHS sample. Statistical inference is based on the Huber-White sandwich matrix, taking into account the influence of the weighting scheme on statistical uncertainty. 15 Age-dependent prevalences of overweight and obesity were illustrated with cubic splines 16 after smoothing the prevalences in each year of age t by using smoothed means over the age span from tÀ2 to t þ 2. For the analyses, ORs were calculated by using normal weight as the reference category. Subjects with a BMI o18.5 kg/m 2 were excluded from these comparisons.
Results
Point prevalence of overweight and obesity
The total primary care point prevalence of overweight and obesity was 37.9% (overweight) and 19.4% (obesity). Rates for overweight in women (32.0%) were considerably lower than for men (46.7%; Po0.0001), whereas rates for obesity were slightly higher in women, due to higher rates of grade 2 (4.0 vs 2.7%; Po0.001) and grade 3 (1.7 vs 1.2%; Po0.001) obesity in women (Table 1 bottom; Total HYDRA ages: 16-Z80). Table 1 also gives an age-and sex-adjusted comparison of the HYDRA primary care data with those from the general population (Table 1 top, age-restricted comparison 18-79). In almost all comparisons, the primary care sample revealed slightly lower rates for overweight and obesity than those found in the community sample. Difference in prevalence rates for overweight (HYDRA: 38.2 vs GHS 39.4%) and for obesity (20.0 vs 20.3%) were significant (Po0.05) for the total rates as well as for the majority of age and sex comparisons. Although these differences are statistically significant, they are overall not substantial in size.
Similar to the primary care sample, findings in the community sample revealed an age-related increase for overweight and obesity up to age group 60-74 y, with slightly lower rates in the 75-79 y old age group (Figure 1 ).
Frequency of overweight and obesity in selected diagnostic groups Table 2 presents the frequency of patients with normal weight, overweight and obesity for patients with various medical diagnoses. Among patients with no diagnosis listed, the rates for overweight were 31.3% and for obesity were 12.1%. In contrast, the presence of any diagnosis was associated with a two-fold higher odds for obesity (23.0%, OR: 2.0) and an increased risk of being overweight (41.7%, OR: 1.3). Overall rates for obesity and overweight increased fairly steadily by the number of additional diagnoses assigned. For example, rates of obesity increased from a low of 12% to a high of over 30% with increasing numbers of diagnoses. This increase does not reflect merely the effect of age, because odds ratios remained significant, even after adjusting for age, gender and interaction effects.
The most frequent diagnoses assigned by the doctors were hypertension (34.0%), followed by bladder/kidney disease (16.9%), diabetes (12.6%) and coronary heart disease (CHD 11.9%). Cancer (3.8%) and amputations (0.4%) were among the least frequent diagnoses. With few exceptions (cancer, anxiety, thyroid disorders), all diagnoses were associated with an increased risk of being obese or overweight; in fact the proportion of normal weight subjects was low for all diagnoses, ranging from 19.9% (diabetes mellitus) to 41.0% (bladder/kidney disease). As compared to patients with no other diagnosis, the highest proportions of obese patients were found for diabetes (36.7%, OR: 3.5) and for patients with diabetic feet (36.2%, OR: 1.5), left ventricular hypertrophy (33.4%, OR:2.5), retinopathy (32.4%, OR: 1.3), hypertension (31.3%, OR: 4.1) and sexual dysfunction (30.1%, OR: 2.0). Strong associations with obesity were also found for stroke (OR: 2.2) and neuropathy (OR: 2.6).
Recognition of overweight and obesity by physicians, prescribed need for weight reduction interventions and actual use While only 20-30% of overweight patients were classified as such by the doctor, improved recognition was seen in more severe cases, with 60-70% of patients of grade 3 obesity being recognized as obese ( Figure 2a ). Younger overweight (Po0.001) and obese patients (Po0.0001) up to grade 1 were recognized and diagnosed considerably less frequently than patients aged 30-44, 45-59, or Z60 y.
Only 39% of all obese patients ( Figure 2b ) reported having ever received in their lifetime (28%) or in the past 12 months (11%) any weight reduction intervention (including interventions of any type to increase physical activity). More importantly, the likelihood of patients receiving any intervention in their lifetime was not related to whether the treating physician recognized the obesity status of the patient or rated an immediate need for weight reduction (41%) or not (20%). Findings for overweight were quite similar (25 vs 43%).
As illustrated in Figure 2b , the majority of overweight and obese patients rated weight reduction interventions as 'not helpful' with regard to weight changes, 36.1% of obese and 28.4% of overweight patients rated 'some success', whereas only 13.6% of the obese and 20.3% of the overweight patients described their past experiences as being helpful. It should be noted that this rating is predominantly based on the lifetime experience with one or two, and only rarely three or more of such interventions. Weight reduction Overweight in primary care patients P Bramlage et al Table 1 Prevalences of overweight/obesity in the total HYDRA primary care sample and with the German Health Survey (% and odds ratios (OR, 95% confidence interval))
Overweight ( OR ¼ Odds ratio from multinomial logistic regressions, the reference groups include the patients with normal weight. ORs among all males and females resp. are adjusted for age-group differences. ORs among the total age groups are adjusted for sex. ORs among the total sample are adjusted for age group, sex and age group * sex. *Po0.05.
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Factors associated with poor weight control in primary care
Results from a multiple regression analysis reveal different association patterns for doctors' recognition and the prediction of actual use of weight loss interventions by the patient. With regard to recognition, females and patients Z45 y had a higher probability to be diagnosed by the doctor as overweight or obese than males or younger patients. The likelihood of being recognized as overweight or obese also increased considerably in the presence of vascular complications when diagnosed with hypertension and diabetes as well as in the presence of multimorbidity (as compared to patients with only one diagnosis) ( Table 3) . For actual use of weight reduction measures, associations were considerably weaker in general. Age did not play a significant role but younger patients tended to use weight reduction measures more frequently than older patients did. On the other hand, women were less likely than male patients to participate in such interventions. Although the presence of vascular complications associated with the diagnosis of hypertension or diabetes tended to increase the likelihood of using interventions, the strength of this association was weak; however, this remained significant only in the multiple model for obesity. Similarly, concerning recognition doctors' competence or affinity played only a minor role, except for obese patients.
Discussion
This paper was stimulated by the fact that, in contrast to a large number of prevalence studies in the general population from across the world, there are to our knowledge virtually no recent large-scale studies that have specifically addressed the situation of overweight and obese patients in primary care. We aimed to investigate the prevalence of overweight and obesity, to put a particular focus on high-risk patients, to describe how frequently excess weight patients are recognized and treated and to explore the factors associated with doctors' recognition and patients' actual use of weight control interventions in primary care.
Prevalence Almost 40% of all primary care patients examined in our study were classified as overweight and an additional 20% were classified as obese. These prevalences varied substantially by age group considered and are overall in good agreement with rates reported for the German general population. But it is worth noting that rates for obesity are still substantially lower than those reported for the US. Overweight in primary care patients P Bramlage et al and 16.5% in women. Similarly, the DHP study (Deutsche Herz-Kreislauf-Präventionsstudie), 18 a representative sample of 4700 inhabitants of former West Germany (1990) aged 25-69 y, reported a prevalence estimate of about 33% for overweight and 18% for obesity.
Prevalence in diagnostic groups
The high proportion of overweight and obese patients among high-risk patients in primary care raises serious concerns. Hypertension, diabetes and cardiovascular morbidities were strongly associated with increased BMI values. Further, there was a clear and consistent relationship between the number of comorbid conditions and excess body weight.
The observation of increased rates of overweight and obesity in some of these disorders is consistent with previous observations. For example in NHANES II, a BMI427 kg/m 2 was associated with a three-fold rate of hypertension in the overall population (20-75 y) and even resulted in a six-fold increase of hypertension in younger patients (20-45 y). 19 Similar associations were reported in the German PROCAM study, which found a continuous increase in hypertension prevalence with an increase in BMI, with a hypertension rate of 23.4% in individuals with a BMI of 25.1-27.5 and a hypertension rate of 47.8% in individuals with a BMI430. 20 Similarly, for type II diabetes, the Nurses Health Study revealed that for women with a BMI430 the risk of diabetes was at least 30 times higher than for women with a BMIo22. 21 In fact, only 10% of type II diabetics had normal weight at the time of diagnosis. 22, 23 Our primary care b The total number of diagnostic classes is 22 plus hypertension and diabetes, obesity was not included. Overweight in primary care patients P Bramlage et al findings that obesity was particularly high among patients with diabetes, but also with its typical complications like diabetic feet, retinopathy, neuropathy and sexual dysfunction, reflect and compliment these data. Particularly interesting was the demonstration of multimorbidity as a function of increasing overweight/obesity rates. Further, we demonstrate that the association of increased BMI and morbidity is at least as pronounced in primary care as in community samples; more than two-thirds (77.8%) of all patients with more than six medical conditions in HYDRA were overweight or obese. The increased burden of comorbidities associated with excess body weight was also reflected by our observation that the proportion of overweight and obese patients was not only high in patients with left ventricular hypertrophy, coronary heart disease and congestive heart failure, but also in patients with the majority of other somatic conditions examined.
Doctors' recognition, need for intervention and actual use Given the negative effect of excess body weight on a wide range of health conditions, it is remarkable that recognition of overweight and obesity by general practitioners appears to be poor and doctors' perceived need for intervention in these patients even worse. While the overall recognition rate of overweight was low, it was even lower in younger patients. Indeed, around 70% of patients with overweight were Overweight in primary care patients P Bramlage et al apparently unrecognized and no need for weight reduction intervention was reported by the treating physician. Disregarding the finding that recognition and need for intervention appeared to be slightly better in higher age groups, the situation for obese patients was only slightly more positive and ranged between a recognition of 50% in the young and a high of 68% in patients aged Z60 y. Apparently, primary care doctors tend to pay attention to overweight and obesity only in older patients and particularly those already manifesting with severe medical conditions. Given that the primary care patients were predominantly seen and treated by their GP for many years and the fact that doctors evidently were for the most part aware about the patients' disease status, underrecognition of overweight and obesity is most likely attributable to the fact that excess bodyweight is not perceived as a clinically significant problem by the physician. It may well be thatFin view of the high prevalence of excess body weight in almost 60% of all patientsFdoctors perceive this to be 'normal' rather than an abnormal condition in most patients. This assumption is consistent with the recent US report by Mokdad et al 24 that
only 42.8% of obese persons who had had a routine checkup in the past year had been advised by their health care professional to lose weight. This has essentially not changed since 1996, at which time this percentage was 42.4%, and prompted a call to physicians to be more involved in weight counseling. 25, 26 The overall lack of recognition, particularly in younger individuals, is clearly unfortunate, as there is evidence indicating that individuals who receive adequate advice and counseling from a health care professional to lose weight are more likely to attempt weight loss than those who do not receive this advice. 25 Another alarming aspect, evident from further analyses in the HYDRA sample, is the fact that even if the doctors had attempted or enforced weight reduction interventions, the majority of obese patients have never receivedFrespectively participated inFany systematic behavioral intervention. Only 39% of all obese patients in primary care reported having ever used such interventions in their lifetime and only 11% did so in the past 12 months. Obviously, neither is the need for intervention judged by the doctor successfully translated into action nor is the compliance of patients, in terms of willingness to encounter such interventions sufficiently high. The situation is even worse in overweight patients. HYDRA provides further hints for what goes wrong from the patients' perspective, by suggesting that existing weight reduction interventions might have only limited attractiveness and patients' perceived efficacy. Only 14% of obese (20% of the overweight) patients rated the success of such interventions as being at least 'helpful'; in contrast, more than 50% rated these interventions as being not 'at all' helpful.
Predictors of recognition and use of interventions A search for factors explaining this unsatisfying situation revealed different patterns of associations for doctors' recognition and the prediction of actual use of interventions by the patient. Females and patients Z45 y had a higher probability of being diagnosed by the doctor as overweight or obese than males or younger patients. Recognition also increased considerably when diagnosed with hypertension and diabetes as well as in the presence of multimorbidity. However, none of the doctors' variables examined as putative predictors contributed significantly to the prediction model; neither doctors' qualification, experience, self-rated competence nor the doctors' greater affinity to the topic of overweight and obesity made powerful contributions.
For actual use of weight reduction measures, effects were considerably weaker. Age did not play a significant role, however, it is noteworthy that younger patients tended to use weight reduction measures more frequently than older patients. Gender effectsFsignificant only for overweightFseemed to direct in the opposite direction than in the recognition model, namely women were less likely than male patients to participate in such interventions.
We can only speculate on the factors that may further contribute to the remarkably poor diagnostic recognition rates in our study and even lower patient utilization rates. Explorative analyses suggest that, in addition to time pressure (average time per patient), general attitudes towards the clinical significance of overweight and the effect of concurrently more acute and seemingly more severe somatic conditions and comorbidities, as well as past frustration with acceptance and effectiveness of weight control interventions Overweight in primary care patients P Bramlage et al all play a critical role. This line of reasoning is also supported by the remarkably low rate of overweight patients (18%) who received or were currently receiving weight reduction intervention at the time of our survey.
Limitations
Despite the strengths of the study (sample size, representativeness, simultaneous coverage of structural, doctors and patients perspective) a few limitations need to be highlighted: (1) the BMI information for the HYDRA study was calculated from self-reported heights and weights. As individuals may tend to under-report weight while overestimating height, 27 overweight and obesity rates may in fact be slightly higher than estimated in our study. (2) Coding of medical diagnoses was based only on clinical appraisal and not validated by objective criteria. Thus, rates for certain conditions like hypertension, diabetes, or nephropathy may well have been considerably higher (7, 10, 12) . However, as the false-positive rate of these diagnoses is probably low, it appears reasonable to assume that the associations found between these disorders and excess body weight represent rather conservative lower bound limits.
Perspective
Our findings seem to signal that simply increasing the awareness of excess body weight and its significant implications for increased morbidity risks, as well as poorer course and outcome, is important but probably not enough. Specifically, the typical comorbid risk constellations of overweight and obesity (for example, for hypertension and diabetes and their complications) should be more specific about the realistic and available treatment options in these patients and might need specific targeted motivational enhancement interventions to increase 'readiness for change' and compliance. At the same time, more effectiveFpossibly combined behavioral and pharmacologicalFweight reduction intervention strategies need to be developed, that address more appropriately the different needs of patients of different age and gender and concomitant diseases.
